Literature DB >> 7336696

[Immunological and etiological aspects of a study of the Aina/1448 serotype of the tick-borne encephalitis virus].

V V Pogodina, N G Bochkova, L S Levina, V Iu Zhezmer, R A Meĭerova.   

Abstract

Blood sera (1488 specimens) of the human population collected in the zone of isolation of tick-borne encephalitis (TBE) virus strains belonging to the Aina/1448 serotype were tested by the neutralization, hemagglutination-inhibition, agar gel diffusion and precipitation, and complement fixation tests with antigens of the Aina/1448 strain and prototype TBE virus strains representing the eastern and western serotypes. The dominating role of the Aina/1448 serotype in the formation of herd immunity in different areas of the forest-steppe and taiga zones of the Irkutsk region was established. Antibody to the Aina/1448 strain was found in the blood of the normal population and patients with acute and chronic forms of TBE. In TBE patients the percentage of virus-neutralizing antibody to the Aina/1448 strain was significantly higher (36.8%) than in the general population (16.6%). These are differences in the structure of immunity in vaccinees and nonvaccinees with TBE vaccine. Sera from the nonvaccinees reacted with the Aina/1448 strain more frequently, sera of the vaccinees more frequently contained antibody to different serotypes of TBE virus. Diagnostic problems and criteria of evaluation of the local antigenic variants of TBE virus are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7336696

Source DB:  PubMed          Journal:  Vopr Virusol        ISSN: 0507-4088


  2 in total

1.  Pathogenesis and immune response of vaccinated and unvaccinated rhesus monkeys to tick-borne encephalitis virus.

Authors:  P Hambleton; J R Stephenson; A Baskerville; C N Wiblin
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

2.  TBEV Subtyping in Terms of Genetic Distance.

Authors:  Andrei A Deviatkin; Galina G Karganova; Yulia A Vakulenko; Alexander N Lukashev
Journal:  Viruses       Date:  2020-10-31       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.